Cardinal Health, Inc. is an American multinational health care services company, and the 14th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| CAH | CARDINAL HEALTH INC | 2025-10-16 15:35:47 | 153.27 | 0 | 0 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAH | 0000721371 | CARDINAL HEALTH INC | US14149Y1082 | CCU46N3GJMF4OK4N7U60 | 310958666 | NYSE | 5122 | Wholesale-Drugs, Proprietaries & Druggists' Sundries | 0630 | OH | 7000 CARDINAL PLACE | DUBLIN | OH | 43017 | UNITED STATES | US | 6147573033 | 7000 CARDINAL PLACE, DUBLIN, OH, 43017 | 7000 CARDINAL PLACE, DUBLIN, OH, 43017 | CARDINAL DISTRIBUTION INC | Healthcare | 1971 | Jason Hollar | 57,700 | http://cardinalhealth.com | 28,372,319,280 | 271,000,000 | 238,793,647 | Cardinal Health, Inc. is an American multinational health care services company, and the 14th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States. | 2025-10-10 19:20:13 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 28,372,319,280 | 3,958,827,607 | 16.2157 | 238,793,647 | -5,051,696 | -2.0717 |
| 2024 | 24,413,491,673 | 4,638,015,845 | 23.4534 | 243,845,343 | -6,836,277 | -2.7271 |
| 2023 | 19,775,475,828 | 5,551,719,501 | 39.0313 | 250,681,620 | -21,830,744 | -8.0109 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Deborah L. Weitzman | Chief Executive Officer | 2025 | 741,932 | 0 | 3,771,217 | 964,511 | 30,197 | 5,507,857 |
| Jason M. Hollar | Chief Executive Officer | 2025 | 1,492,329 | 0 | 13,431,441 | 3,551,742 | 500,683 | 18,976,195 |
| Stephen M. Mason | Chief Executive Officer | 2025 | 741,932 | 0 | 3,357,917 | 593,545 | 51,650 | 4,745,044 |
| Aaron E. Alt | Chief Financial Officer | 2025 | 871,164 | 0 | 3,977,813 | 1,303,262 | 57,796 | 6,210,035 |
| Jason M. Hollar | Chief Executive Officer | 2024 | 1,434,153 | 0 | 20,640,912 | 3,112,112 | 464,032 | 25,651,209 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 57,700 |
| 2024 | 48,900 |
| 2023 | 48,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 222,578,000,000 | 226,827,000,000 | 205,012,000,000 |
| Cost Of Revenue | 214,410,000,000 | 219,413,000,000 | 198,123,000,000 |
| Gross Profit | 8,168,000,000 | 7,414,000,000 | 6,889,000,000 |
| Research And Development Expenses | — | — | — |
| General And Administrative Expenses | 5,382,000,000 | 5,000,000,000 | 4,834,000,000 |
| Operating Expenses | 202,386,000,000 | — | — |
| Operating Income | 2,275,000,000 | 1,243,000,000 | 727,000,000 |
| Net Income | 1,561,000,000 | 852,000,000 | 261,000,000 |
| Earnings Per Share Basic | 6.48 | 3.48 | 1 |
| Earnings Per Share Diluted | 6.45 | 3.45 | 1 |
| Weighted Average Shares Outstanding Basic | 241,000,000 | 245,000,000 | 261,000,000 |
| Weighted Average Shares Outstanding Diluted | 242,000,000 | 247,000,000 | 262,000,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 3,874,000,000 | 5,133,000,000 | 4,043,000,000 |
| Marketable Securities Current | — | 200,000,000 | — |
| Accounts Receivable | 13,242,000,000 | 12,084,000,000 | 11,344,000,000 |
| Inventories | 16,831,000,000 | 14,957,000,000 | 15,940,000,000 |
| Non Trade Receivables | 7,000,000 | 14,000,000 | 9,000,000 |
| Other Assets Current | 2,414,000,000 | 2,663,000,000 | 2,362,000,000 |
| Total Assets Current | 36,373,000,000 | 34,884,000,000 | 33,833,000,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 2,858,000,000 | 2,529,000,000 | 2,462,000,000 |
| Other Assets Non Current | 1,714,000,000 | 1,258,000,000 | 1,041,000,000 |
| Total Assets Non Current | 16,749,000,000 | 10,237,000,000 | 9,584,000,000 |
| Total Assets | 53,122,000,000 | 45,121,000,000 | 43,417,000,000 |
| Accounts Payable | 34,713,000,000 | 31,759,000,000 | 29,813,000,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 550,000,000 | 434,000,000 | 792,000,000 |
| Other Liabilities Current | — | — | — |
| Total Liabilities Current | 38,897,000,000 | 35,640,000,000 | 33,706,000,000 |
| Long Term Debt | 7,977,000,000 | 4,658,000,000 | 3,909,000,000 |
| Other Liabilities Non Current | — | — | — |
| Total Liabilities Non Current | -38,710,000,000 | — | — |
| Total Liabilities | 187,000,000 | — | — |
| Common Stock | 2,956,000,000 | 2,917,000,000 | 2,747,000,000 |
| Retained Earnings | 783,000,000 | -286,000,000 | -534,000,000 |
| Accumulated Other Comprehensive Income | -155,000,000 | -167,000,000 | -151,000,000 |
| Total Shareholders Equity | -2,781,000,000 | -3,213,000,000 | -2,852,000,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 790,000,000 | 710,000,000 | 692,000,000 |
| Share Based Compensation Expense | 244,000,000 | 121,000,000 | 96,000,000 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | 833,000,000 | 996,000,000 | 947,000,000 |
| Change In Inventories | 1,816,000,000 | -1,115,000,000 | 340,000,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | 2,732,000,000 | 1,824,000,000 | 2,718,000,000 |
| Change In Other Liabilities | 606,000,000 | 433,000,000 | 967,000,000 |
| Cash From Operating Activities | 2,397,000,000 | 3,762,000,000 | 2,839,000,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 547,000,000 | 511,000,000 | 481,000,000 |
| Acquisition Of Business | 5,250,000,000 | 1,190,000,000 | 10,000,000 |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -5,593,000,000 | -1,849,000,000 | -454,000,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | 765,000,000 | 750,000,000 | 2,000,000,000 |
| Issuance Of Long Term Debt | 2,900,000,000 | 1,140,000,000 | — |
| Repayment Of Long Term Debt | 445,000,000 | 783,000,000 | 579,000,000 |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | 1,940,000,000 | -847,000,000 | -3,051,000,000 |
| Change In Cash | -1,259,000,000 | 1,057,000,000 | -674,000,000 |
| Cash At End Of Period | 3,874,000,000 | 5,133,000,000 | 4,043,000,000 |
| Income Taxes Paid | 444,000,000 | 191,000,000 | 156,000,000 |
| Interest Paid | 315,000,000 | 214,000,000 | 203,000,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | 6.48 | 3.48 | 1 |
| Price To Earnings Ratio | 25.9259 | 28.092 | 94.57 |
| Earnings Growth Rate | 86.2069 | 248 | -129.8507 |
| Price Earnings To Growth Ratio | 0.3007 | 0.1133 | -0.7283 |
| Book Value Per Share | 219.6473 | 38.698 | 37.2069 |
| Price To Book Ratio | 0.7649 | 2.5262 | 2.5417 |
| Ebitda | 3,010,000,000 | 1,804,000,000 | 1,202,000,000 |
| Enterprise Value | 45,141,000,000 | 23,910,200,000 | 25,340,770,000 |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | -3.0662 | -1.5848 | -1.6483 |
| Capital Expenditures | 1,119,000,000 | 777,000,000 | 793,000,000 |
| Free Cash Flow | 1,278,000,000 | 2,985,000,000 | 2,046,000,000 |
| Return On Equity | -0.5613 | -0.2652 | -0.0915 |
| One Year Beta | 0.4237 | 0.0755 | 0.4647 |
| Three Year Beta | 0.3915 | 0.4553 | 0.5723 |
| Five Year Beta | 0.4911 | 0.735 | 0.7889 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Hollar Jason M. | Chief Executive Officer | 2025-08-20 | 12,944 | D | 222,957 |
| Hollar Jason M. | Chief Executive Officer | 2025-08-20 | 22,957 | D | 200,000 |
| WEITZMAN DEBORAH | CEO, PSS Segment | 2025-08-20 | 21,367 | D | 53,428 |
| Snow Ola M | Chief Human Resources Officer | 2025-08-19 | 23,700 | D | 19,882 |
| Snow Ola M | Chief Human Resources Officer | 2025-08-19 | 4,451 | D | 15,431 |
| Name Of Reporting Person | Type Of Reporting Person | Report Date | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Kelly Loeffler | Senator | 2020-05-01 | Purchase | 2020-04-07 | Spouse | $1,001 - $15,000 |
| Kelly Loeffler | Senator | 2020-05-01 | Purchase | 2020-03-20 | Spouse | $100,001 - $250,000 |
| Robert P Corker, Jr. | Senator | 2015-12-11 | Sale (Full) | 2014-05-20 | Self | $1,001 - $15,000 |
| Robert P Corker, Jr. | Senator | 2015-12-11 | Purchase | 2014-01-08 | Self | $1,001 - $15,000 |
| Robert P Corker, Jr. | Senator | 2015-07-14 | Sale (Full) | 2014-05-20 | Self | $1,001 - $15,000 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Marjorie Taylor Greene | 2025-05-19 | GA14 | Purchase | 2025-05-14 | — | $1,001 - $15,000 |
| Rob Bresnahan | 2025-05-08 | PA08 | Purchase | 2025-04-08 | — | $1,001 - $15,000 |
| Marjorie Taylor Greene | 2025-05-06 | GA14 | Purchase | 2025-05-05 | — | $1,001 - $15,000 |
| Marjorie Taylor Greene | 2025-03-19 | GA14 | Purchase | 2025-03-17 | — | $1,001 - $15,000 |
| Marjorie Taylor Greene | 2025-01-27 | GA14 | Purchase | 2025-01-21 | — | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Bill Few Associates, Inc. | 2025-09-30 | 202,008 | 1,287 | 156.9604 |
| WILLNER & HELLER, LLC | 2025-09-30 | 205,338 | 1,308 | 156.9862 |
| Columbus Macro, LLC | 2025-09-30 | 5,733,574 | 36,529 | 156.9595 |
| Lowe Wealth Advisors, LLC | 2025-09-30 | 10,987 | 70 | 156.9571 |
| MEYER HANDELMAN CO | 2025-09-30 | 2,343,727 | 14,932 | 156.96 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| ADVISORS' INNER CIRCLE FUND | 2025-07-31 | Institutional Class Shares | LSVVX | 2,900 | 450,138 | 0.3534 |
| VICTORY PORTFOLIOS III | 2025-07-31 | Victory Global Managed Volatility Fund Shares | UGMVX | 3,042 | 472,179.24 | 0.0997 |
| VICTORY PORTFOLIOS III | 2025-07-31 | Victory Global Managed Volatility Fund Institutional Shares | UGOFX | 3,042 | 472,179.24 | 0.0997 |
| VICTORY PORTFOLIOS III | 2025-07-31 | Victory Capital Growth Fund Institutional Shares | UICGX | 37,418 | 5,808,021.96 | 0.5936 |
| VICTORY PORTFOLIOS III | 2025-07-31 | Victory Capital Growth Fund Shares | USCGX | 37,418 | 5,808,021.96 | 0.5936 |